Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In addition to weight reduction, the Phase 2 trial reported improvements in several cardiometabolic markers, including: Reductions in waist circumference Improvements in blood pressure Favourable changes in lipid profiles Reductions in fasting glucose and insulin resistance Increases in heart rate were also observed, consistent with findings seen with other incretin-based therapies These findings suggest that retatrutide may offer broader metabolic benefits beyond weight loss alone, which is particularly relevant for patients with obesity-related comorbidities such as type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), or elevated cardiovascular risk
Larger syringes sacrifice precision for capacity, so choose the smallest syringe that can hold your required dose
but we also learned from our research that consumers found that increasing their protein consumption helped with nausea," Hagan said
Expect better appetite suppression in the follicular phase and more hunger, cravings, and water retention in the luteal phase
Avoid Overuse - Stick to the recommended dosage and frequency to prevent potential side effects and to ensure the best results
US$ 25.23
US$ 25.34
US$ 27.29
US$ 21.51
